Pharma partners, Transgenomic and Amgen have entered into a collaborative R&D agreement to develop a CE-IVD test to screen patients with metastatic colorectal cancer for RAS mutations. Read the full story
Tag Archive | "collaborative R&D"
Merck in Type II Diabetes pharma partnering with Abide Therapeutics
Posted on 03 May 2013
Merck, a top big pharma company has inked a collaborative R&D pharma partnering agreement with Abide Therapeutics to discover, develop and commercialize small-molecule therapies directed against three novel targets to treat metabolic diseases with a focus on type 2 diabetes Read the full story
Allergan & Molecular Partners extend pharma alliances with $1.5 billion exclusive pact
Posted on 23 August 2012
Allergan, a big pharma company and Molecular Partners AG have significantly expanded their existing pharma alliances relationship by entering into two separate agreements to discover, develop, and commercialize proprietary therapeutic DARPin products for the treatment of serious ophthalmic diseases.
Eisai pharma partners with Verastem for Wnt inhibitors
Posted on 12 July 2012
Verastem announced a pharma partners research collaboration with Eisai for the next-generation of small molecule Wnt inhibitors.
Abbot pharma alliances with ChemDiv Research for collaborative R&D
Posted on 11 July 2012
Abbott, one of the top 10 big pharma companies have signed a pharma alliances agreement with ChemDiv Research Institute to launch several R&D projects in Russia.
Sanofi joins forces with Joslin Diabetes Center as pharma allainces for diabetes research
Posted on 20 June 2012
Sanofi, a top big pharma giant collaborated with Joslin Diabetes Center, a teaching and research affiliate of Harvard Medical School, in a pharma alliances agreement to promote the development of new medicines for the treatment of diabetes and related disorders.
Roche signs biotech deals with Seaside Therapeutics to develop disease modifying treatments
Posted on 20 June 2012
Roche, a big pharma and big biotech lister has signed biotech deals with Seaside Therapeutics to develop disease modifying treatments for fragile X syndrome (FXS) and autism spectrum disorders (ASD), both neurodevelopmental disorders for which there are currently no effective pharmacological treatments that address core symptoms.
Big pharma GSK enters into a collaborative R&D pact with KineMed
Posted on 19 June 2012
KineMed announced a multi-year R&D collaboration with GlaxoSmithKline, a big pharma company that will apply KineMed’s proprietary biomarker discovery platform in therapeutic areas of interest to GSK.
Big pharma Gilead signs R&D pharma partnering deal with Adimab
Posted on 20 April 2012
Adimab and Gilead Sciences, a top big pharma company have initiated a pharma partnering research collaboration to identify therapeutic antibodies against two targets selected by Gilead Read the full story
Collaborative R&D and manufacturing pharma partnering agreement for Adcretis
Posted on 12 April 2012
Seattle Genetics and Millennium have formed a pharma partnering collaboration with Ventana Medical Systems Read the full story
